Oncology and Hematology
Episodes 129-144 of 300
Noa Biran, MD
Joseph Mikhael, MD
Joseph Mikhael, MD
Noa Biran, MD
Joseph Mikhael, MD
- Project Oncology®
Diving into the Efficacy & Tolerability of mBC Treatment
Pavani Chalasani, MD, MPH
Colleen Bohnenkamp, PharmD, BCPS, BCOP
Sara M. Tolaney MD, MPH
Sara A. Hurvitz, MD, FACP
Sara M. Tolaney MD, MPH
- MinuteCE®
What Is the Evidence for ADCs in HR-/HER2-Low Metastatic Breast Cancer?
1.00 program creditSara M. Tolaney MD, MPH
Sara A. Hurvitz, MD, FACP
- MinuteCE®
What Do Patients/Caregivers Need To Know About ADCs in Metastatic TNBC?
1.00 program creditSara M. Tolaney MD, MPH
Sara A. Hurvitz, MD, FACP
- MinuteCE®
How Are We Addressing Unanswered Questions Around ADCs in Metastatic TNBC?
1.00 program creditSara A. Hurvitz, MD, FACP
Sara M. Tolaney MD, MPH
Sara A. Hurvitz, MD, FACP
Sara M. Tolaney MD, MPH
Sara A. Hurvitz, MD, FACP